Cited in the vast majority of clinical papers, and employed in nearly every clinical trial to date on PIPAC, the CapnoPen® is the gold standard amongst laparoscopic nebulization devices.
CapnoPen® technology, made in Germany, relies on injectors tested millions of times in the automotive industry.
CapnoPen® is able to aerosolize a large range of substances, including saline solutions, emulsions and nanoparticles, with a stable median droplet size around 30 µm.
CapnoPen® is CE-certified and its safety has been verified in numerous clinical studies and in over 15 000 clinical applications worldwide.
Based on this unique experience, CapnoPharm develops next generation devices, which will enter clinical practice soon.